Guidelines for the Control of Methicillin-resistant Staphylococcus Aureus in New Zealand
(2002; 71 pages)


These guidelines have been developed in response to the changing epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in New Zealand. The process involved reviewing the previous guidelines, local epidemiological data, other published guidelines, and relevant recent research. This document is not a policy to be rigidly followed by all health care facilities for the control of MRSA. It is a set of guidelines that should be used by an individual facility to develop its own MRSA policy. However, it is strongly recommended that facilities within a region reach local consensus on how to manage MRSA. This is particularly important for the transfer of colonised patients between health care facilities.

The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017